Hematopoietic growth factors—use in normal blood and stem cell donors: clinical and ethical issues
2008; Wiley; Volume: 48; Issue: 9 Linguagem: Inglês
10.1111/j.1537-2995.2008.01788.x
ISSN1537-2995
AutoresJeffrey McCullough, Jeffrey Kahn, John W. Adamson, Paolo Anderlini, Richard J. Benjamin, Dennis L. Confer, Mary Eapen, Betsy Hirsch, David J. Kuter, Ellen Lazarus, Derwood Pamphilon, David Stroncek, Jeremy Sugarman, Robert Wilson,
Tópico(s)Blood transfusion and management
ResumoTransfusionVolume 48, Issue 9 p. 2008-2025 Hematopoietic growth factors—use in normal blood and stem cell donors: clinical and ethical issues Summary of a conference Co-Chairs Jeffrey McCullough, Co-Chairs Jeffrey McCullough From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorJeffrey Kahn, Jeffrey Kahn From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorSpeakers John Adamson, Speakers John Adamson From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorPaolo Anderlini, Paolo Anderlini From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorRichard Benjamin, Richard Benjamin From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorDennis Confer, Dennis Confer From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorMary Eapen, Mary Eapen From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorBetsy Hirsch, Betsy Hirsch From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorDavid Kuter, David Kuter From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorEllen Lazarus, Ellen Lazarus From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorDerwood Pamphilon, Derwood Pamphilon From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorDavid Stroncek, David Stroncek From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorJeremy Sugarman, Jeremy Sugarman From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorRobert Wilson, Robert Wilson From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this author Co-Chairs Jeffrey McCullough, Co-Chairs Jeffrey McCullough From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorJeffrey Kahn, Jeffrey Kahn From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorSpeakers John Adamson, Speakers John Adamson From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorPaolo Anderlini, Paolo Anderlini From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorRichard Benjamin, Richard Benjamin From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorDennis Confer, Dennis Confer From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorMary Eapen, Mary Eapen From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorBetsy Hirsch, Betsy Hirsch From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorDavid Kuter, David Kuter From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorEllen Lazarus, Ellen Lazarus From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorDerwood Pamphilon, Derwood Pamphilon From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorDavid Stroncek, David Stroncek From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorJeremy Sugarman, Jeremy Sugarman From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this authorRobert Wilson, Robert Wilson From the University of Minnesota and National Marrow Donor Program, Minneapolis, Minnesota; Blood Center of Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin; MD Anderson Cancer Center, Houston, Texas; American Red Cross Biomedical Services, Washington, DC; Massachusetts General Hospital, Boston, Massachusetts; Food and Drug Administration, Rockville, Maryland; University of Bristol, Bristol, UK; the National Institutes of Health, Bethesda, Maryland; and Johns Hopkins University, Baltimore, Maryland.Search for more papers by this author First published: 01 September 2008 https://doi.org/10.1111/j.1537-2995.2008.01788.xCitations: 20 Jeffrey McCullough, University of Minnesota, Minneapolis, MN 55455; e-mail: mccul001@umn.edu. This research was supported by grants from the National Basic Research Program of China (2002CB713804). The findings and conclusions in this article have not been formally disseminated by the Food and Drug Administration and should not be construed to represent any Agency determination or policy. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume48, Issue9September 2008Pages 2008-2025 RelatedInformation
Referência(s)